Canine Distemper (CDV) Testing: Complete Guide¶
Canine distemper virus (CDV) is a multisystemic morbillivirus affecting respiratory, gastrointestinal, and neurological systems. Early detection matters because neurological cases carry a poor prognosis.
When to Test¶
| Signal | Action |
|---|---|
| Fever + respiratory signs + ocular/nasal discharge | Test |
| Neurological signs (myoclonus, seizures) in young dog | Test |
| Unexplained illness in unvaccinated dog | Test |
| Outbreak investigation | Test + isolate |
Detection Strategy¶
| Test | Target | Notes |
|---|---|---|
| Antigen (nucleoprotein) | Virus | Detects active infection; best early |
| Antibody | Immune response | Exposure/vaccination; rises later |
For acute diagnosis, antigen detection is preferred; antibody testing reflects exposure or vaccination.
Sample Selection¶
The sample site matters for CDV antigen detection:
| Sample site | When to use |
|---|---|
| Conjunctival swab | Early respiratory phase — highest early sensitivity |
| Nasal swab | Respiratory signs |
| Blood (buffy coat) | Systemic / viremic phase |
| CSF | Neurological disease (specialized) |
Caveat: neurological distemper may no longer shed virus in accessible sites — a negative does not exclude neurological CDV.
Result Interpretation¶
| Result | Interpretation |
|---|---|
| Antigen positive + compatible signs | Consistent with distemper |
| Antigen negative, early signs | Retest — viral load may be low early |
| Antibody positive | Exposure or vaccination — not proof of active disease |
| Antigen negative + neurological signs | Does not exclude neurological CDV |
Vaccination Interference¶
Modified-live CDV vaccines can produce transient antigen positivity and, more durably, antibody. Interpret results with the vaccination history:
- A recently vaccinated dog may be antigen-positive transiently.
- Antibody positivity is expected after vaccination and does not indicate active disease.
Clinical Decision Flow¶
Suspected CDV (fever + respiratory/ocular/nasal signs, young dog)
↓
Antigen test (conjunctival/nasal) ── positive ──→ Isolate + supportive care
↓ negative
Neurological signs? ── yes ──→ Guarded prognosis; specialist workup
↓ no
Early phase? ── yes ──→ Retest in 24–48 h
Prognosis by Phase¶
| Phase | Prognosis |
|---|---|
| Respiratory / GI (early) | Fair with supportive care |
| Neurological (myoclonus, seizures) | Guarded to poor |
| Recovery | May have permanent sequelae (e.g., enamel hypoplasia, neuro signs) |
FAQ¶
Does vaccination interfere with CDV testing? Vaccination can produce antibody (and, transiently, antigen) — correlate with clinical signs and vaccination history.
What is the prognosis for neurological distemper? Guarded to poor — which is why early, pre-neurological detection is clinically valuable.
Which sample is best for early detection? Conjunctival swabs often yield the earliest positive in the respiratory phase.
Case Study: The Rescue Litter¶
A 3-month-old, unvaccinated mixed-breed puppy from a rescue group presents with fever (40.2 °C), purulent ocular/nasal discharge, and a dry cough. Two days later, the puppy develops twitching of the jaw muscles.
- CDV antigen (conjunctival swab): positive.
- CRP: 48 mg/L — marked systemic inflammation.
Management: Isolation, intravenous fluids, broad-spectrum antibiotics for secondary bacterial pneumonia, and supportive care. With the onset of myoclonus, the prognosis was discussed with the rescue: neurological distemper carries a guarded outcome.
Lesson: The same-visit antigen result confirmed distemper during the respiratory phase — before the neurological signs were fully established. Early detection enables earlier isolation (protecting the rest of the litter) and honest prognostic counseling.
References¶
- Sarchahi AA, Arbabi M, Mohebalian H. Detection of canine distemper virus in cerebrospinal fluid, whole blood and mucosal specimens of dogs with distemper using RT-PCR and immunochromatographic assays. Vet Med Sci. 2022;8(4):1390-1399. PMID: 35363942
- Greene CE. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier; 2012. (Canine distemper chapter)
- Day MJ, Horzinek MC, Schultz RD, Squires RA. WSAVA Guidelines for the vaccination of dogs and cats. J Small Anim Pract. 2016.
For the review policy, see the Editorial & Review Policy.
Authored by: Migibio Clinical & Scientific Affairs, Guangzhou Magic Biotech Co., Ltd.
Reviewed by: Migibio R&D Quality Committee
Last updated: 2026-08-14
Disclosure: Migibio (Guangzhou Magic Biotech Co., Ltd.) is the manufacturer of the FIA680/FIA880 analyzers and FICT reagents referenced in this content. See our Editorial & Review Policy.